Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...